Garchik Stephen Jeffrey 4
4 · authID Inc. · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
authID (AUID) 10% Owner Stephen Garchik Buys Stock
What Happened
Stephen J. Garchik, a reported 10% owner of authID Inc. (AUID), acquired 120,482 shares of common stock in an open-market/private purchase on 2026-04-29 at about $1.25 per share (~$150,000). The filing also shows acquisition of 1,000,000 warrants (recorded at $0) with a $1.50 exercise price and a five‑year term; the warrants are not exercisable until 10/29/2026 per the filing footnote. The share purchase is a cash buy (a purchase), which many investors view as a more informative signal than routine sales; the warrants are a derivative instrument, not immediate shares.
Key Details
- Transaction date(s): 2026-04-29; Form 4 filed 2026-05-01 (filed within the normal reporting window).
- Purchase: 120,482 shares @ ~$1.25 each (filing lists $1.25; footnote F2 gives $1.245) — total ≈ $150,000.
- Derivative: 1,000,000 warrants recorded at $0; exercise price $1.50; 5‑year term; not exercisable until 10/29/2026 (footnote F2).
- Holdings/vehicles: Shares/warrants held by the Garchik Irrevocable 2019 Trust (Mr. Garchik is trustee). Other footnotes reference holdings via Garchik Universal LP (joint control) and Marla Garchik Irrevocable 2020 Trust (beneficiary).
- Beneficial ownership note: F1 disclaims beneficial ownership beyond Mr. Garchik’s pecuniary interest.
- Options vesting notes (F5, F6) appear in the filing but relate to other option grants and are not the transactions reported here.
- Shares owned after the transaction: not specified in the excerpted filing details.
Context
The 120k share purchase was a straightforward cash acquisition. The 1,000,000 warrants are a derivative grant with a future exercise price and a lock/unexercisable period — they do not immediately increase share count until exercised. As a 10% owner (not necessarily an executive), Garchik’s purchases and derivative holdings are important to monitor but should be viewed with other company and market information rather than as standalone investment advice.
Insider Transaction Report
- Purchase
Common Stock
[F1][F2]2026-04-29$1.25/sh+120,482$150,000→ 291,316 total(indirect: See Footnotes) - Purchase
Stock Purchase Warrant
[F1][F2]2026-04-29+1,000,000→ 1,000,000 total(indirect: See Footnotes)Exercise: $1.50From: 2026-10-29Exp: 2031-04-29→ Common Stock, $0.0001 par value per share (1,000,000 underlying)
- 1,073,563
Common Stock
- 130,975(indirect: See Footnotes)
Common Stock
[F1][F3] - 147,627(indirect: See Footnotes)
Common Stock
[F1][F4] - 38,024
Stock Options
[F5]Exercise: $3.90From: 2025-09-04Exp: 2035-09-04→ Common Stock, $0.0001 par value per share (38,024 underlying) - 12,500
Stock Options
[F6]Exercise: $3.90From: 2025-09-04Exp: 2035-09-04→ Common Stock, $0.0001 par value per share (12,500 underlying)
Footnotes (6)
- [F1]Stephen J. Garchik ("Mr. Garchik") disclaims beneficial ownership of any and all of the Issuer's securities reported herein in excess of his actual pecuniary interest.
- [F2]Held by the Garchik Irrevocable 2019 Trust of which Mr. Garchik is a trustee. Includes the acquisition on 4/29/2026 of 120,482 shares of Common Stock at $1.245 per share and 1,000,000 warrants to purchase Common Stock (exercise price $1.50, 5-year term, not exercisable until 10/29/2026).
- [F3]Held by Garchik Universal Limited Partnership, which Mr. Garchik jointly controls with his sister.
- [F4]Held by Marla Garchik Irrevocable 2020 Trust of which Mr. Garchik is a beneficiary.
- [F5]The shares underling the stock options vest monthly over a period of 12 months.
- [F6]The shares underling the stock options vest annually over a period of three years.